Hims & Hers Health Inc (NYSE:HIMS) shares traded 5.09% higher at $41.89 on Wall Street last session.
HIMS stock price is now 17.68% away from the 50-day moving average and 73.58% away from the 200-day moving average. The market capitalization of the company currently stands at $9.31B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $42 to $60, Morgan Stanley Downgraded its rating from Overweight to Equal-Weight for Hims & Hers Health Inc (NYSE: HIMS). On January 10, 2025, Citigroup Downgraded its previous ‘Neutral’ rating to ‘Sell’ on the stock increasing its target price from $24 to quote $25, while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, Chi Michael, Chief Commercial Officer sold 17,303 shares of the company’s stock on Feb 24 ’25. The stock was sold for $832,966 at an average price of $48.14. Upon completion of the transaction, the Chief Commercial Officer now directly owns 193,601 shares in the company, valued at $8.11 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 24 ’25, Officer Chi Michael bought 17,303 shares of the business’s stock. A total of $832,966 was incurred on buying the stock at an average price of $48.14. A total of 18.37% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $9.67 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 1.79, and a quick ratio of 1.50.
The net profit margin was 8.54% and return on equity was 30.71% for HIMS. The company reported revenue of $481.14 million for the quarter, compared to $246.62 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 95.09 percent.
